Literature DB >> 1335166

Retinoids selective for retinoid X receptor response pathways.

J M Lehmann1, L Jong, A Fanjul, J F Cameron, X P Lu, P Haefner, M I Dawson, M Pfahl.   

Abstract

Retinoids have a broad spectrum of biological activities and are useful therapeutic agents. Their physiological activities are mediated by two types of receptors, the retinoic acid receptors (RARs) and the retinoid X receptors (RXRs). RARs, as well as several related receptors, require heterodimerization with RXRs for effective DNA binding and function. However, in the presence of 9-cis-retinoic acid, a ligand for both RARs and RXRs, RXRs can also form homodimers. A series of retinoids is reported that selectively activates RXR homodimers but does not affect RAR-RXR heterodimers and thus demonstrates that both retinoid response pathways can be independently activated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1335166     DOI: 10.1126/science.1335166

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  63 in total

Review 1.  The retinoid X receptors and their ligands.

Authors:  Marcia I Dawson; Zebin Xia
Journal:  Biochim Biophys Acta       Date:  2011-10-01

2.  All trans retinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell lymphoma.

Authors:  Amareshwar T K Singh; Andrew M Evens; Reilly J Anderson; Jennifer A Beckstead; Natesan Sankar; Antonella Sassano; Savita Bhalla; Shuo Yang; Leonidas C Platanias; Trudy M Forte; Robert O Ryan; Leo I Gordon
Journal:  Br J Haematol       Date:  2010-05-09       Impact factor: 6.998

3.  A histone deacetylase inhibitor potentiates retinoid receptor action in embryonal carcinoma cells.

Authors:  S Minucci; V Horn; N Bhattacharyya; V Russanova; V V Ogryzko; L Gabriele; B H Howard; K Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

4.  Retinoid-induced chromatin structure alterations in the retinoic acid receptor beta2 promoter.

Authors:  N Bhattacharyya; A Dey; S Minucci; A Zimmer; S John; G Hager; K Ozato
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

5.  Distinct stages in adipogenesis revealed by retinoid inhibition of differentiation after induction of PPARgamma.

Authors:  J C Xue; E J Schwarz; A Chawla; M A Lazar
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

6.  Cell-type and promoter-context dependent retinoic acid receptor (RAR) redundancies for RAR beta 2 and Hoxa-1 activation in F9 and P19 cells can be artefactually generated by gene knockouts.

Authors:  R Taneja; B Roy; J L Plassat; C F Zusi; J Ostrowski; P R Reczek; P Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

7.  A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers.

Authors:  V Vivat; C Zechel; J M Wurtz; W Bourguet; H Kagechika; H Umemiya; K Shudo; D Moras; H Gronemeyer; P Chambon
Journal:  EMBO J       Date:  1997-09-15       Impact factor: 11.598

8.  Nurr1-RXR heterodimers mediate RXR ligand-induced signaling in neuronal cells.

Authors:  Asa Wallen-Mackenzie; Alexander Mata de Urquiza; Susanna Petersson; Francisco J Rodriguez; Stina Friling; Joseph Wagner; Peter Ordentlich; Johan Lengqvist; Richard A Heyman; Ernest Arenas; Thomas Perlmann
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

Review 9.  Chemoprevention of colorectal cancer.

Authors:  M Langman; P Boyle
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

10.  The histone acetylase PCAF is a nuclear receptor coactivator.

Authors:  J C Blanco; S Minucci; J Lu; X J Yang; K K Walker; H Chen; R M Evans; Y Nakatani; K Ozato
Journal:  Genes Dev       Date:  1998-06-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.